The day's most important urology news, ranked by evidence. Free daily briefing, residency & fellowship program navigation and a verified message board.
The UrologyMatch team is back together!
Meet UrologyWatch: daily urology news, the Residency Navigator, Sub-I and interview ratings, a verified message board, clinical trials, podcasts and more.
Built for the whole urology community: https://t.co/J1GS6nBRSR
▸ FDA grants Fast Track to T-cell engager VIR-5500 for prostate cancer
▸ Higher chemotherapy dose and testicular radiation linked to abnormal pubertal hormone patterns in childhood cancer survivors
This evening on UrologyWatch, Oct 11: https://t.co/UQYtlKusVz
New: the UrologyWatch URPS Fellowship Navigator.
The 16 urology-accredited Urogynecology and Reconstructive Pelvic Surgery programs, plus a toggle for OB/GYN programs, the ERAS and NRMP timeline and an applicant board.
https://t.co/dnFseNrKzI
① Second-look TURBT linked to better high-grade recurrence-free survival in high-risk NMIBC
② Augmentation cystoplasty shows durable urodynamic benefit over median 19 years in spinal cord injury
Today's urology Top 5, Oct 11: https://t.co/UQYtlKusVz
▸ Perilesional cores catch csPCa missed by targeting; systematic cores mainly add low-grade disease
▸ Cloquet's node identified as dominant site of lymphatic leak causing lymphoceles after RP
This evening on UrologyWatch, Oct 10: https://t.co/UQYtlKv0L7
New: the UrologyWatch Pediatric Urology Fellowship Navigator.
All 33 programs in one place, with contacts, side-by-side comparison, the AUA match timeline, interview dates as programs post them and an applicant board.
https://t.co/ry4AQZcqeh
New villain in the BlackCloud universe! 🌩️
Not in the mood for board / inservice prep questions? Try Classic Mode for pure arcade fun.
🎮 Play at: https://t.co/dSgJfiY4OA
#Urology#MedEd
① Novel sulfonic acid stent coating cuts encrustation and symptoms in randomized trial
② PROTAC AR degrader bavdegalutamide shows activity in AR mutation subgroup in mCRPC
Today's urology Top 5, Oct 10: https://t.co/UQYtlKusVz
▸ Disitamab vedotin plus tislelizumab tested in unresectable HER2-positive NMIBC
▸ Decipher genomic classifier and Artera AI tool show moderate correlation in prostate cancer
This evening on UrologyWatch, Oct 9: https://t.co/UQYtlKv0L7
We are so honored to welcome Dr Jay Raman @urojdr@PSH_Urology as our visiting professor.
His lecture on “The Flow of Discovery” outline his road to advancing understanding, guidelines & therapeutic modalities for #hematuria & #utuc has left us inspired
Coaching is not for people who are struggling. It is for people with goals who want to reach them more intentionally. 🎯
Dr. Helen Bernie (@drhelenbernie) talks with Dr. Emilie Johnson (@eekayjay) and Dr. Angie Smith (@angiesmith_uro) on BackTable Urology about coaching, mentorship, and the frameworks that help urologists grow.
This podcast was developed in collaboration with @SWIUorg.
Listen now in the BackTable app🎧: https://t.co/C7EkcKdeom
#URO334 #Urology #CareerCoaching #WomenInUrology #SWIU
① PSMA PET/MRI outperforms MRI-targeted biopsy for equivocal PI-RADS 3 lesions
② Radical cystectomy with urinary diversion linked to higher fracture risk, especially in women
Today's urology Top 5, Oct 9: https://t.co/UQYtlKusVz
New on UrologyWatch: Black Cloud, a game about urology call.
Three consults, nine calls, one very bad night. Scope the tumor, drain the infected kidney, beat the clock to the OR, and make the right call when the consult pauses.
Can you make Chief?
https://t.co/LZLyDvzON8
▸ CAIX-targeted imaging may improve clear cell RCC staging
▸ Umbrella review finds low-quality evidence behind intracavernosal BoNT-A for refractory ED
This evening on UrologyWatch, Oct 8: https://t.co/UQYtlKv0L7
Last endourology match: 73 positions, 19 unfilled, and 26 applicants who ranked programs did not match. Fit matters.
Compare all 59 Society programs by track:
https://t.co/RXleu487Dz
Or look outside the match at standalone robotic fellowships:
https://t.co/ELT8ttW4M1
New on UrologyWatch: two free fellowship navigators.
Endourology: all 59 US and Canadian programs by track, with the case numbers programs report.
https://t.co/RXleu47zO1
Robotic surgery: standalone fellowships that hire directly, outside the match.
https://t.co/ELT8ttVwWt
① Post-chemo RPLND for seminoma: 84% 5-yr survival in viable seminoma cases, 27% relapsed overall
② Aquablation shows similar safety and efficacy as salvage therapy after prior BPH surgery
Today's urology Top 5, Oct 8: https://t.co/UQYtlKusVz
New on UrologyWatch: the GURS Fellowship Navigator.
All 29 reconstruction fellowships, with each program's case mix from the public GURS year-end logs set against the GURS minimums, plus deadlines, contacts and an application checklist.
Free: https://t.co/dgaSMAh24w
▸ Surgical delay of 43+ days to nephroureterectomy linked to worse overall survival in UTUC
▸ Modeled indirect comparison suggests DFS benefit for pembrolizumab-belzutifan vs surveillance in RCC
This evening on UrologyWatch, Oct 7: https://t.co/UQYtlKusVz